Recent Bioscience Sector releases

Healthcare Companies Capitalizing on a Resurgent Biotech Industry

 [PRESSWIRE] LAS VEGAS, March 20, 2018 -- The healthcare sector has always been one of the best performing industries in the stock market over the last several decades. In fact, since 1963 the healthcare sector has generated an annualized rate of return of 11 percent. Included in today's commentary: Endonovo Therapeutics, Inc. (OTC: ENDV), Athersys, Inc. (NASDAQ: ATHX), Caladrius Biosciences (NASDAQ: CLBS), ARCA Biopharma, Inc. (NASDAQ: ABIO), Geron Corporation (NASDAQ: GERN).

Micell Technologies Announces Expanded Patent Estate

 [PRESSWIRE] DURHAM, North Carolina, March 20, 2018 -- Micell® Technologies, Inc., a privately-held, development-stage biomedical company, today provided an update on its recently expanded intellectual property portfolio.

AGC Biologics Expands Capacity at Berkeley, California Facility

 [PRESSWIRE] BERKELEY, California, March 6, 2018 -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their Berkeley, California facility is adding to its growing capacity with the addition of a 2000L single-use bioreactor (SUB).

Partners Agree on Initial Funding to Kick Off Waste-to-chemistry Project in Rotterdam

 [PRESSWIRE] MONTREAL, February 16, 2018 -- A consortium of companies comprising Air Liquide, AkzoNobel Specialty Chemicals, Enerkem and the Port of Rotterdam has signed a project development agreement covering initial investments in an advanced waste-to-chemistry facility in Rotterdam.

Enterome Raises €32 Million ($38.5 Million) in a Series D Financing

 [PRESSWIRE] PARIS and CAMBRIDGE, Massachusetts, January 4, 2018 -- ENTEROME SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, announces that it has raised €32 million in a Series D financing.

JHL Biotech Welcomes New Chief Medical Officer, Rong Chen

 [PRESSWIRE] HSINCHU, Taiwan and WUHAN, China, Jan. 1, 2018 -- JHL Biotech announced that Rong Chen has been appointed Chief Medical Officer effective January 1. As CMO, Dr. Chen will oversee JHL's medical and clinical development work as part of its mission to make world-class biopharmaceuticals affordable and available to more patients.

Santa Claus and Rudolph the green-nosed reindeer are on a mission to fight global warming

[PRESSWIRE] ROLLE, SWITZERLAND and the Arctic Circle, Finland - 19 December, 2017 -- Santa’s famous and much beloved reindeer are part of the ruminant animal family and therefore produce harmful greenhouse gases. It is said that Santa’s nine reindeer in total travel more than 342 million kilometres around the world on their mission to deliver Christmas presents to eager children, and as a result produce roughly 15 tons of methane gas a year.

High-Nitrate Energy Boost from Amaranth

[PRESSWIRE] KERALA, India, November 23, 2016 -- A new, clinical study confirms that dietary supplementation of nitrate from a natural extract of Amaranthus species nicknamed "red spinach," results in a significant increase in plasma nitrite that ultimately enhances nitric oxide.

OGT Announces Commercial and Financial Highlights for FY 2016

[PRESSWIRE] OXFORD, England, November 22, 2016 -- Oxford Gene Technology (OGT), The Molecular Genetics Company has announced continued strong sales of its highly integrated molecular genetics product portfolio, delivering sustainable, profitable growth.

Outcome Capital Expands to Europe With New UK Operations

[PRESSWIRE] BOSTON & LONDON - 28 September, 2016 -- Outcome Capital, LLC (www.outcomecapital.com), an investment banking firm that serves middle market growth companies in life sciences and technology markets, today announced the firm has expanded its operations into Europe with a UK office in London. The company has appointed Shawn Manning, D. Phil., as Managing Director of the new office.